The Patent Finder

Terms ending in 2037

Genesis Intelligence, LLC

Every in-force patent on Genesis Intelligence, LLC's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 12,178,576Early Detection of Neurodegenerative Disease
In force
 · High confidence
Genesis Intelligence, LLCIn forceHigh confidence
US 11,096,653Networked Electronic Stethoscope
In force
 · High confidence
Genesis Intelligence, LLCIn forceHigh confidence
US 12,070,320Neuroanal Ytic, Neurodiagnostic, and Therapeutic Tools
In force
 · Medium confidence
Genesis Intelligence, LLCIn forceMedium confidence
US 10,799,186Detection Of Disease Conditions And Comorbidities
In force
 · High confidence
Genesis Intelligence, LLCIn forceHigh confidence
US 11,504,038Early Detection of Neurodegenerative Disease
In force
 · High confidence
Genesis Intelligence, LLCIn forceHigh confidence
US 11,490,851Neuroanalytic, Neurodiagnostic, and Therapeutic Tools
In force
 · High confidence
Genesis Intelligence, LLCIn forceHigh confidence
US 12,458,299Detection Of Disease Conditions And Comorbidities
In force
 · High confidence
Genesis Intelligence, LLCIn forceHigh confidence
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited